Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:05 pm Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Logos Global Management LP | 150,000 0.400% | 150,000 (New Position) | Filing History |
| 2022-02-14 1:38 pm Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | BIOTECHNOLOGY VALUE FUND L P | 3,114,532 7.500% | 282 (+0.01%) | Filing History |
| 2022-02-14 11:33 am Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Eventide Asset Management, LLC | 3,514,909 8.800% | 3,514,909 (New Position) | Filing History |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Ally Bridge MedAlpha Master Fund L.P. | 1,501,591 3.800% | -121,000 (-7.46%) | Filing History |
| 2022-02-11 1:34 pm Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | JANUS HENDERSON GROUP PLC JHG | 2,515,254 6.300% | 2,515,254 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | BlackRock Inc. BLK | 2,698,654 6.800% | 2,698,654 (New Position) | Filing History |
| 2022-01-25 11:32 am Unchanged | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Atlas Venture Fund IX L.P. | 916,196 2.300% | 0 (Unchanged) | Filing History |
| 2021-11-17 3:39 pm Purchase | 2021-11-05 | 13G | Cogent Biosciences, Inc. COGT | TCG Crossover Management LLC | 2,716,042 6.800% | 706,054 (+35.13%) | Filing History |
| 2021-11-03 5:31 pm Purchase | 2021-10-07 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 2,141,339 5.400% | 2,141,339 (New Position) | Filing History |
| 2021-07-08 1:50 pm Purchase | 2021-06-28 | 13G | Cogent Biosciences, Inc. COGT | TCG Crossover Management LLC | 2,009,988 5.200% | 2,009,988 (New Position) | Filing History |
| 2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | Ridgeback Capital Investments L.P. | 1,252,250 5.200% | 1,252,250 (New Position) | Filing History |
| 2021-02-16 3:21 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | Logos Global Master Fund LP | 1,920,500 5.700% | 1,920,500 (New Position) | Filing History |
| 2021-02-12 4:15 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | Ally Bridge MedAlpha Master Fund L.P. | 1,622,591 5.100% | 1,622,591 (New Position) | Filing History |
| 2021-02-12 09:58 am Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | RTW Investments, LP | 1,998,750 3.170% | 740,000 (+58.79%) | Filing History |
| 2021-02-11 4:52 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | BIOTECHNOLOGY VALUE FUND L P | 3,114,250 4.700% | 3,114,250 (New Position) | Filing History |
| 2021-02-02 1:02 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | Atlas Venture Fund IX L.P. | 916,196 8.080% | 916,196 (New Position) | Filing History |